/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Gossamer Bio Inc Share Price Today: Live Updates & Key Insights

Gossamer Bio Inc share price today is $0.408, up -6.55%. The stock opened at $0.44635 against the previous close of $0.452, with an intraday high of $0.4482 and low of $0.4.

Gossamer Bio Inc Share Price Chart

style
pb-0

Gossamer Bio Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Gossamer Bio Inc Share Price Performance

$0.408 -0.0655(-6.55%) GOSS at 23 Mar 2026 01:21 PM Biotechnology
Lowest Today 0.4
Highest Today 0.4482
Today’s Open 0.44635
Prev. Close 0.452
52 Week High 3.87
52 Week Low 0.33
Day’s Range: Low 0.4 High 0.4482
52-Week Range: Low 0.33 High 3.87
1 day return -
1 Week return -9.86
1 month return -1.26
3 month return -88.98
6 month return -86.85
1 year return -67.34
3 year return -62.63
5 year return -95.71
10 year return -

Gossamer Bio Inc Institutional Holdings

NEA Management Company, LLC 7.82

Octagon Capital Advisors LP 6.01

BlackRock Inc 5.98

Vanguard Group Inc 5.56

ARCH VENTURE CORP 3.48

Samsara BioCapital, LLC 3.12

Vanguard Total Stock Mkt Idx Inv 2.99

Palo Alto Investors, LLC 2.36

Siren, L.L.C. 2.25

State Street® SPDR® S&P® Biotech ETF 2.25

683 Capital Management LLC 2.24

Acadian Asset Management LLC 2.17

Hillhouse Capital Advisors, Ltd. 2.15

Geode Capital Management, LLC 2.11

iShares Russell 2000 ETF 2.06

FMR Inc 1.83

Fidelity Select Biotechnology 1.82

State Street Corp 1.68

Perceptive Advisors LLC 1.65

Millennium Management LLC 1.55

Two Sigma Investments LLC 1.47

Rock Springs Capital Management LP 1.41

Bank of America Corp 1.25

UBS Group AG 1.20

Vanguard Institutional Extnd Mkt Idx Tr 0.96

Fidelity Small Cap Index 0.81

iShares Russell 2000 Growth ETF 0.70

iShares Biotechnology ETF 0.60

State St Russell Sm/Mid Cp® Indx SL Cl I 0.49

Xtrackers S&P 500 Swap ETF 1C 0.47

Fidelity Extended Market Index 0.47

Schwab US Small-Cap ETF™ 0.43

Vanguard Russell 2000 ETF 0.40

Federated Hermes Kaufmann Small Cap A 0.33

Federated Hermes Kaufmann Small Cap Grow 0.33

State St Russell Sm Cap® Indx SL Cl I 0.29

Vanguard Health Care ETF 0.24

Blackrock Extended Mkt Fund CF 0.24

iShares Micro-Cap ETF 0.22

Schwab Small Cap Index 0.21

Gossamer Bio Inc Market Status

Strong Buy: 4

Buy: 3

Hold: 2

Sell: 0

Strong Sell: 0

Gossamer Bio Inc Fundamentals

Market Cap 99.14 M

PB Ratio 2.6638

PE Ratio 0.0

Enterprise Value 165.11 M

Total Assets 172.25 M

Volume 29612173

Gossamer Bio Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-187433000 -187.4M, FY22:-240228000 -240.2M, FY21:-249076000 -249.1M, FY20:-251584000 -251.6M, FY19:-180818000 -180.8M

Quarterly Revenue Q3/2025:13294000 13.3M, Q2/2025:11489000 11.5M, Q1/2025:9889000 9.9M, Q3/2024:9480000 9.5M, Q2/2024:95842000 95.8M

Quarterly Profit Q3/2025:13294000 13.3M, Q2/2025:11489000 11.5M, Q1/2025:9889000 9.9M, Q3/2024:9480000 9.5M, Q2/2024:94850000 94.9M

Quarterly Net worth Q3/2025:-48221000 -48.2M, Q2/2025:-38273000 -38.3M, Q1/2025:-36638000 -36.6M, Q3/2024:-30803000 -30.8M, Q2/2024:49232000 49.2M

About Gossamer Bio Inc & investment objective

Company Information Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.

Organisation Biotechnology

Employees 161

Industry Biotechnology

CEO Mr. Faheem Hasnain

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Gossamer Bio Inc FAQs

What is the share price of Gossamer Bio Inc today?

The current share price of Gossamer Bio Inc is $0.408.

Can I buy Gossamer Bio Inc shares in India?

Yes, Indian investors can buy Gossamer Bio Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Gossamer Bio Inc shares in India?

You can easily invest in Gossamer Bio Inc shares from India by:

Can I buy fractional shares of Gossamer Bio Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Gossamer Bio Inc?

Gossamer Bio Inc has a market cap of $99.14 M.

In which sector does Gossamer Bio Inc belong?

Gossamer Bio Inc operates in the Biotechnology sector.

What documents are required to invest in Gossamer Bio Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Gossamer Bio Inc?

The PE ratio of Gossamer Bio Inc is N/A and the PB ratio is 2.66.